Evaluation of the Prognostic Value of Long Noncoding RNAs in Lung Squamous Cell Carcinoma

Figure 7

Difference of the stromal score and the immune score between the high- and low-risk group in OS in the training set (a), test set (b), and entire set (c). The difference of the stromal score and the immune score between the high- and low-risk groups in DFS (d–f).

(a)

(b)

(c)

(d)

(e)

(f)